Home/Filings/4/0001437749-18-016607
4//SEC Filing

JOSEPH THOMIS 4

Accession 0001437749-18-016607

CIK 0000811212other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 2:48 PM ET

Size

4.9 KB

Accession

0001437749-18-016607

Insider Transaction Report

Form 4
Period: 2018-09-04
Transactions
  • Other

    Common Stock

    2018-09-0435,0000 total(indirect: By Thomis Consulting BVBA)
Footnotes (1)
  • [F1]On August 28, 2018, an affiliate of the Reporting Person agreed to purchase 35,000 shares in a private offering from the Issuer for an aggregate purchase price of $6,300, as reported in a Form 4 filed by the Reporting Person on August 30, 2018. However, for the purposes of complying with certain rules of the Nasdaq Capital Market, the transaction was mutually rescinded on September 4, 2018 prior to the issuance of the shares and the completion of the transaction.

Issuer

CESCA THERAPEUTICS INC.

CIK 0000811212

Entity typeother

Related Parties

1
  • filerCIK 0001694611

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 2:48 PM ET
Size
4.9 KB